Zevia CFO’s “Sell‑to‑Cover” Moves Spark Insider‑Sale Frenzy as Share Price Plummets 48% YTD

Insider Activity at Zevia PBC: A Closer Look at Satya Girish’s Recent Trades

Satya Girish, the chief financial officer of Zevia PBC, reported a “sell to cover” transaction on March 25, 2026, disposing of 41,662 shares of Class A common stock to meet tax withholding obligations tied to the vesting of 96,671 restricted‑stock‑unit (RSU) awards. The sale price averaged $1.18 per share, slightly above the market close of $1.17, and left Girish holding 327,909 shares post‑transaction. The next day, Girish exercised a significant portion of his 2021 Equity Incentive Plan—453,901 RSUs were granted, vesting in quarterly increments, and the transaction was recorded as a “buy” for zero cost, reflecting the nature of RSU awards.

This pattern of selling to cover and then acquiring new RSUs is not unusual for executive officers who must manage tax exposure while maintaining long‑term ownership stakes. However, the timing coincides with a broader wave of insider selling at Zevia, notably a $3.5 million block sold by a Quebec depository bank in January 2026 and a 40,000‑share sale by executive Spence Padraic L. for $1.44 each earlier in March. The cumulative effect of these sales has tightened the company’s liquidity profile, contributing to a steep decline in the share price—down 27 % month‑to‑date and 48 % year‑to‑date—against a 52‑week high of $3.66.

From an investor’s perspective, Girish’s recent actions suggest a cautious but committed stance. The sale to cover taxes is a mechanical move, while the simultaneous grant of RSUs indicates confidence in Zevia’s future value. The company’s ongoing Rule 144 filings and S‑8 registration of up to 11 million shares under the 2021 plan further signal a readiness to replenish equity pools and potentially unlock new capital. Nevertheless, the current negative price‑earnings ratio of –7.7 and sustained downtrend in share price may temper enthusiasm, especially as the market perceives the company’s growth trajectory as sluggish.

Looking ahead, the RSU grants could serve as a catalyst for future upside if Zevia can execute on its product expansion and operational efficiencies. Yet, the heavy insider selling pressure and lack of recent earnings guidance could deter short‑term traders. For long‑term investors, the key will be monitoring whether the new RSUs translate into tangible performance improvements and whether the company can reverse its declining valuation trend without additional dilutive equity issuances.